EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking

Tanzila Akter Eity iD, Md Shimul Bhuia iD, Raihan Chowdhury iD, Salehin Sheikh iD, Siddique Akber Ansari, Nowreen Tabassum Ahammed, Hossam Kamli, Muhammad Torequl Islam iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70524 ↗

At a glance

Journal article in Brain and Behavior, 2025. Written by Tanzila Akter Eity and 7 co-authors. Institution: Department of Biotechnology and Genetic Engineering, Gopalganj Science and Technology University, Gopalganj, Bangladesh. Major MEDLINE topics: Hypnotics and Sedatives, Sesquiterpenes. Cited 1 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Lonicerin (LON) has been identified to have different biological properties, such as anticancer, anti‐inflammatory, immunomodulatory, antibacterial, antimicrobial, and neuroprotective. This study aims to assess the sedative effect of LON in Swiss albino mice, which is yet to be discovered. Materials and Methods: Mice were treated with two different doses of LON (5 and 10 mg/kg) and 2 mg/kg of diazepam (DZP), which is the referral GABAergic medication, and the latency time and sleeping duration of animals were observed. A computational study was also conducted to evaluate the docking scores and display the binding sites of LON and receptor (GABA A α1 and β2 subunits). The study also investigated the pharmacokinetics and drug‐likeness properties of LON along with toxicological analysis by using SwissADME and Protox‐3 software, respectively.

Results

Findings revealed that the higher concentration of LON reduced the latency (9.86 ± 1.44 min) and increased the sleep duration (191.29 ± 7.43 min) compared to the lower concentration. Besides, the combination group of LON and DZP showed the lowest latency (6.17 ± 0.82 min) and highest sleeping time (219.00 ± 6.39 min). In the in silico study, LON exhibited a strong docking score (−8.1 kcal/mol) with the macromolecules, which is closer to the binding affinity of DZP (–8.3 kcal/mol), indicating that LON could show strong sedative activity by binding with the GABA A receptor. Computational toxicity analysis revealed that LON is non‐hepatotoxic, non‐neurotoxic, noncarcinogenic, noncytotoxic, non‐ecotoxic, and non‐mutagenic.

Conclusion

Therefore, LON may be effective for the treatment of insomnia in the near future.

Subjects

MeSH terms (MEDLINE)

Hypnotics and SedativesSesquiterpenesAnimalsMolecular Docking SimulationMiceReceptors, GABA-ADiazepamMaleSleep

Author keywords

Insomnialonicerinnatural productneuroprotectivepharmacokinetictoxicity

Substances

Hypnotics and SedativesReceptors, GABA-ADiazepamSesquiterpenes

Authors and institutions

  • Department of Biotechnology and Genetic Engineering, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
  • Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh.
  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Department of Biology, Touro University, New York City, New York, USA.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.

ORCID profiles: Tanzila Akter Eity, Md Shimul Bhuia, Raihan Chowdhury, Salehin Sheikh, Muhammad Torequl Islam

Cite

APA

Eity, T. A., Bhuia, M. S., Chowdhury, R., Sheikh, S., Ansari, S. A., Ahammed, N. T., Kamli, H., & Islam, M. T. (2025). Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking. Brain and Behavior. https://doi.org/10.1002/brb3.70524

Vancouver

Eity TA, Bhuia MS, Chowdhury R, Sheikh S, Ansari SA, Ahammed NT, et al. Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking. Brain and Behavior. 2025. doi:10.1002/brb3.70524

BibTeX
@article{Eity2025,
  author = {Eity, Tanzila Akter and Bhuia, Md Shimul and Chowdhury, Raihan and Sheikh, Salehin and Ansari, Siddique Akber and Ahammed, Nowreen Tabassum and Kamli, Hossam and Islam, Muhammad Torequl},
  title = {Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70524}
}
Start for free →